alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2014372EN.01000501.xml

| 20.10.2014 | EN | Official Journal of the European Union | C 372/5 |
| --- | --- | --- | --- |

20.10.2014

EN

Official Journal of the European Union

C 372/5

---

Request for a preliminary ruling from the Finanzgericht Köln (Germany) lodged on 14 August 2014 — Timac Agro Deutschland GmbH v Finanzamt Sankt Augustin

(Case C-388/14)

2014/C 372/08

Language of the case: German

Referring court

Referring court

Finanzgericht Köln

Parties to the main proceedings

Parties to the main proceedings

Applicant: Timac Agro Deutschland GmbH

Applicant:

Defendant: Finanzamt Sankt Augustin

Defendant:

Questions referred

Questions referred

| 1. | Is Article 49 TFEU (Article 43 EC) to be interpreted as precluding a provision such as Article 52(3) of the Einkommensteuergesetz (Law on income tax, ‘EStG’), in so far as the cause of the reinstatement of an amount corresponding to losses of a foreign permanent establishment previously taken into account by way of a tax reduction is the sale of that permanent establishment to another company limited by shares within the same group as the seller, and not the making of profits? |
| --- | --- |

1.

Is Article 49 TFEU (Article 43 EC) to be interpreted as precluding a provision such as Article 52(3) of the Einkommensteuergesetz (Law on income tax, ‘EStG’), in so far as the cause of the reinstatement of an amount corresponding to losses of a foreign permanent establishment previously taken into account by way of a tax reduction is the sale of that permanent establishment to another company limited by shares within the same group as the seller, and not the making of profits?

| 2. | Is Article 49 TFEU (Article 43 EC) to be understood as precluding a provision such as Article 23(1)(a) of the DBA Deutschland/Österreich 2000 (2000 Double taxation convention between Germany and Austria) — according to which income from Austria is to be exempt from the basis of assessment for German taxation if that income can be taxed in Austria — if losses accrued in an Austrian permanent establishment of a German company limited by shares can no longer be taken into account in Austria because the permanent establishment is sold to an Austrian company limited by shares belonging to the same group as the German company? |
| --- | --- |

2.

Is Article 49 TFEU (Article 43 EC) to be understood as precluding a provision such as Article 23(1)(a) of the DBA Deutschland/Österreich 2000 (2000 Double taxation convention between Germany and Austria) — according to which income from Austria is to be exempt from the basis of assessment for German taxation if that income can be taxed in Austria — if losses accrued in an Austrian permanent establishment of a German company limited by shares can no longer be taken into account in Austria because the permanent establishment is sold to an Austrian company limited by shares belonging to the same group as the German company?

---
EXHIBIT 32
----------




                            CERTIFICATIONS OF
           CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
                   PURSUANT TO 18 U.S.C. SECTION 1350,
                AS ADOPTED PURSUANT TO SECTION 906 OF THE
                       SARBANES-OXLEY ACT OF 2002
           ---------------------------------------------------



      The following statement is provided by the undersigned to accompany
the Quarterly Report on Form 10-Q for the quarter ended March 31, 2008,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be
deemed filed pursuant to any provision of the Securities Exchange Act of
1934 or any other securities law:

      Each of the undersigned certifies that the foregoing Report on
Form 10-Q fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 (15 U.S.C. 78m) and that the information
contained in the Form 10-Q fairly presents, in all material respects, the
financial condition and results of operations of ALP Liquidating Trust.




                                        /s/   Gary Nickele
                                        ------------------------------
                                        Gary Nickele
                                        Chief Executive Officer




                                        /s/   Gailen J. Hull
                                        ------------------------------
                                        Gailen J. Hull
                                        Chief Financial Officer and
                                        Principal Accounting Officer
§ 200.50 Ophthalmic preparations and dispensers. ( a ) ( 1 ) Informed medical opinion is in agreement that all preparations offered or intended for ophthalmic use, including preparations for cleansing the eyes, should be sterile. It is further evident that such preparations purport to be of such purity and quality as to be suitable for safe use in the eye.
( 2 ) The Food and Drug Administration concludes that all such preparations, if they are not sterile, fall below their professed standard of purity or quality and may be unsafe. In a statement of policy issued on September 1, 1964, the Food and Drug Administration ruled that liquid preparations offered or intended for ophthalmic use that are not sterile may be regarded as adulterated within the meaning of section 501(c) of the Federal Food, Drug, and Cosmetic Act (the act), and, further, may be deemed misbranded within the meaning of section 502(j) of the act. This ruling is extended to affect all preparations for ophthalmic use. By this regulation, this ruling is applicable to ophthalmic preparations that are regulated as drugs. By the regulation in § 800.10 of this chapter, this ruling is applicable to ophthalmic preparations that are regulated as medical devices.
( 3 ) The containers of ophthalmic preparations shall be sterile at the time of filling and closing, and the container or individual carton shall be so sealed that the contents cannot be used without destroying the seal. The packaging and labeling of ophthalmic preparations that are over-the-counter drugs shall also comply with § 211.132 of this chapter on tamper-resistant packaging requirements.
( b ) Liquid ophthalmic preparations packed in multiple-dose containers should: ( 1 ) Contain one or more suitable and harmless substances that will inhibit the growth of microorganisms; or
( 2 ) Be so packaged as to volume and type of container and so labeled as to duration of use and with such necessary warnings as to afford adequate protection and minimize the hazard of injury resulting from contamination during use.
( c ) Eye cups, eye droppers, and other dispensers intended for ophthalmic use should be sterile, and may be regarded as falling below their professed standard of purity or quality if they are not sterile. These articles, which are regulated as drugs if packaged with the drugs with which they are to be used, should be packaged so as to maintain sterility until the package is opened and be labeled, on or within the retail package, so as to afford adequate directions and necessary warnings to minimize the hazard of injury resulting from contamination during use.
[40 FR 13996, Mar. 27, 1975, as amended at 47 FR 50455, Nov. 5, 1982]
IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

CHARLES E. LUCAS,

Petitioner :

:

:

:

:

:

:

:

:

:

: No. 366 WAL 2018

Petition for Allowance of Appeal from

the Order of the Superior Court

ORDER

PER CURIAM

AND NOW , this 13th day of February, 2019

, the Petition for Allowance of Appeal

is DENIED

.
§ 582.5306 Ferric sodium pyrophosphate. ( a ) *Product.* Ferric sodium pyrophosphate.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing or feeding practice.
<TABLE> <S> <C>


<ARTICLE>                           5
<LEGEND>

This schedule  contains summary financial  information  extracted from RIVERSIDE
PARK ASSOCIATES  LIMITED  PARTNERSHIP 2000 First Quarter 10-QSB and is qualified
in its entirety by reference to such 10-QSB filing.

</LEGEND>

<CIK>                               0000813812
<NAME>                             RIVERSIDE PARK ASSOCIATES LIMITED PARTNERSHIP
<MULTIPLIER>                                           1,000


<S>                                   <C>
<PERIOD-TYPE>                       3-MOS
<FISCAL-YEAR-END>                   DEC-31-2000
<PERIOD-START>                      JAN-01-2000
<PERIOD-END>                        MAR-31-2000
<CASH>                                                 3,154
<SECURITIES>                                               0
<RECEIVABLES>                                            592
<ALLOWANCES>                                               0
<INVENTORY>                                                0
<CURRENT-ASSETS>                                           0 <F1>
<PP&E>                                                76,885
<DEPRECIATION>                                        37,925
<TOTAL-ASSETS>                                        43,265
<CURRENT-LIABILITIES>                                      0 <F1>
<BONDS>                                               44,632
<PREFERRED-MANDATORY>                                      0
<PREFERRED>                                                0
<COMMON>                                                   0
<OTHER-SE>                                            (3,448)
<TOTAL-LIABILITY-AND-EQUITY>                          43,265
<SALES>                                                    0
<TOTAL-REVENUES>                                       3,331
<CGS>                                                      0
<TOTAL-COSTS>                                              0
<OTHER-EXPENSES>                                       3,368
<LOSS-PROVISION>                                           0
<INTEREST-EXPENSE>                                     1,099
<INCOME-PRETAX>                                            0
<INCOME-TAX>                                               0
<INCOME-CONTINUING>                                        0
<DISCONTINUED>                                             0
<EXTRAORDINARY>                                            0
<CHANGES>                                                  0
<NET-INCOME>                                             (37)
<EPS-BASIC>                                           (63.60)<F2>
<EPS-DILUTED>                                              0
<FN>

<F1> Registrant has an unclassified balance sheet. <F2> Multiplier is 1.

</FN>


</TABLE>
I 

118TH CONGRESS 

2D SESSION H. R. 7562 

To amend the Federal Reserve Act to prohibit Federal reserve banks from 

paying interest on excess reserves. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 6, 2024 

Mr. DAVIDSON introduced the following bill; which was referred to the 

Committee on Financial Services 

A BILL 

To amend the Federal Reserve Act to prohibit Federal 

reserve banks from paying interest on excess reserves. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Prohibition on IOER 

5 Act of 2024’’. 

6 SEC. 2. PROHIBITION ON PAYMENT OF EARNINGS ON SUR7 PLUS RESERVES. 

8 Section 19(b)(12) of the Federal Reserve Act (12 

9 U.S.C. 461(b)(12)) is amended— 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7562 IH

1 (1) in the heading, by inserting ‘‘REQUIRED RE2 SERVE’’ before ‘‘BALANCES’’; 

3 (2) in subparagraph (A), by inserting after 

4 ‘‘Balances’’ the following: ‘‘of reserves required to be 

5 maintained by a depository institution under para6 graph (2) that are’’; 

7 (3) by redesignating subparagraph (C) as sub8 paragraph (D); and 

9 (4) by inserting after subparagraph (B) the fol10 lowing: 

11 ‘‘(C) PROHIBITION ON OTHER EARN12 INGS.—A Federal reserve bank may not pay 

13 earnings on balances maintained at a Federal 

14 reserve bank by or on behalf of a depository in15 stitution except as provided under this para16 graph.’’. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS
§ 573.130 Aminoglycoside 3′-phospho- transferase II. The food additive aminoglycoside 3′-phosphotransferase II may be safely used in the development of genetically modified cotton, oilseed rape, and tomatoes in accordance with the following prescribed conditions: ( a ) The food additive is the enzyme aminoglycoside 3′-phosphotransferase II (CAS Reg. No. 58943-39-8) which catalyzes the phosphorylation of certain aminoglycoside antibiotics, including kanamycin, neomycin, and gentamicin.
( b ) Aminoglycoside 3′-phosphotransferase II is encoded by the *kan* r gene originally isolated from transposon Tn*5* of the bacterium *Escherichia coli.*
( c ) The level of the additive does not exceed the amount reasonably required for selection of plant cells carrying the *kan* r gene along with the genetic material of interest.
[59 FR 26711, May 23, 1994]
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S UNAUDITED FINANCIAL STATEMENTS AS OF AND FOR THE PERIOD ENDING JULY 1,
2000, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-30-2000
<PERIOD-END>                               JUL-01-2000
<CASH>                                          20,477
<SECURITIES>                                         0
<RECEIVABLES>                                   73,591
<ALLOWANCES>                                       500
<INVENTORY>                                    283,605
<CURRENT-ASSETS>                               458,745
<PP&E>                                         322,126
<DEPRECIATION>                                 104,949
<TOTAL-ASSETS>                               1,180,368
<CURRENT-LIABILITIES>                          427,209
<BONDS>                                        223,777
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        47,247
<OTHER-SE>                                     401,184
<TOTAL-LIABILITY-AND-EQUITY>                 1,180,368
<SALES>                                      1,036,693
<TOTAL-REVENUES>                             1,036,693
<CGS>                                          862,302
<TOTAL-COSTS>                                  862,302
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              14,961
<INCOME-PRETAX>                                  7,523
<INCOME-TAX>                                     3,400
<INCOME-CONTINUING>                              4,123
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,123
<EPS-BASIC>                                       0.09
<EPS-DILUTED>                                     0.09


</TABLE>
IES Order Number: 378304 

Registry Number: 

CA Index Name: 

CAS 

Please print the above CA Index Name on the appropriate page of your PMN. 

If this box is checked, CAS has made correction(s) marked in red to your IES order. 

Please make the same corrections to your PMN before submitting it to the EPA. 

2540 Olentangy River Road P.O. Box 3343 Columbus, OH 4321 0-0334 USA
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          FEB-28-2001
<PERIOD-START>                             MAR-01-2000
<PERIOD-END>                               MAY-31-2000
<CASH>                                           6,513
<SECURITIES>                                         0
<RECEIVABLES>                                   19,195
<ALLOWANCES>                                         0
<INVENTORY>                                    282,735
<CURRENT-ASSETS>                                     0
<PP&E>                                           8,473
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 341,822
<CURRENT-LIABILITIES>                                0
<BONDS>                                         70,692
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,500
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   341,822
<SALES>                                         65,034
<TOTAL-REVENUES>                                     0
<CGS>                                           50,646
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 7,657
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               4,783
<INCOME-PRETAX>                                  1,680
<INCOME-TAX>                                       336
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                    945
<CHANGES>                                            0
<NET-INCOME>                                     2,289
<EPS-BASIC>                                        .17
<EPS-DILUTED>                                      .17


</TABLE>
- All
            - Title
            - Author
            - Subject
            - Date
            - Full-Text

            -                              Explore                            ******                - Educational Resources
              - Archival Collections
              -                                      Themes                                    ******                  - Economic Data
                - Federal Reserve
                - View all 
              - Timelines 
            -                              Browse                            ******                - Titles
              - Authors
              - Subjects
              - Dates 
            -                              About                            ******                - About FRASER
              - FAQ
              - Contact Us
              -                                      FRASER API                                    ******                  - REST API
                - OAI-PMH 
            - Inside FRASER Blog

            - **

Home                 > Browse by Title > Tomorrow's Manpower Needs: Research Report on Manpower Projection Methods

              																	United States. Bureau of Labor Statistics. 						*Tomorrow's Manpower Needs: Research Report on Manpower Projection Methods : Bulletin of the United States Bureau of Labor Statistics, No. 1769*,												Washington, D.C: 								For sale by the Supt. of Docs., U.S. Govt. Print. Off., 										1973,									https://fraser.stlouisfed.org/title/4864,			accessed on September 12, 2024.						    

        - **FRASER**
        - About
        - FAQ
        - Legal and Privacy
        - FRASER API

          -                              @FedFRASER 
          - ** Contact Us
          -  **  What's New  
          -  **  Inside FRASER
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THERMO
POWER CORPORATION'S QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED MARCH
29, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JAN-03-1998
<PERIOD-END>                               MAR-29-1997
<CASH>                                          36,768
<SECURITIES>                                         0
<RECEIVABLES>                                   19,765
<ALLOWANCES>                                       571
<INVENTORY>                                     16,494
<CURRENT-ASSETS>                                83,070
<PP&E>                                          19,045
<DEPRECIATION>                                   8,571
<TOTAL-ASSETS>                                 110,820
<CURRENT-LIABILITIES>                           26,659
<BONDS>                                            278
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,249
<OTHER-SE>                                      64,616
<TOTAL-LIABILITY-AND-EQUITY>                   110,820
<SALES>                                         57,611
<TOTAL-REVENUES>                                57,611
<CGS>                                           47,864
<TOTAL-COSTS>                                   47,864
<OTHER-EXPENSES>                                 1,271
<LOSS-PROVISION>                                     9
<INTEREST-EXPENSE>                                   9
<INCOME-PRETAX>                                  1,177
<INCOME-TAX>                                       642
<INCOME-CONTINUING>                                379
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       379
<EPS-PRIMARY>                                      .03
<EPS-DILUTED>                                        0
        


</TABLE>
# C_2014388EN.01000501.xml

| 3.11.2014 | EN | Official Journal of the European Union | C 388/5 |
| --- | --- | --- | --- |

3.11.2014

EN

Official Journal of the European Union

C 388/5

---

Request for a preliminary ruling from the Klagenævnet for Udbud (Denmark) lodged on 20 August 2014 — MT Højgaard A/S and Züblin A/S v Banedanmark

(Case C-396/14)

2014/C 388/06

Language of the case: Danish

Referring court

Referring court

Klagenævnet for Udbud

Parties to the main proceedings

Parties to the main proceedings

Applicants: MT Højgaard A/S and Züblin A/S

Applicants:

Defendant: Banedanmark

Defendant:

Question referred

Question referred

Is the principle of equal treatment in Article 10, cf. Article 51 of Directive 2004/17/EC (1) of the European Parliament and of the Council to be interpreted as precluding, in situation such as the one at issue here, a contracting authority from awarding the contract to a tenderer which had not applied for pre-selection and therefore was not pre-selected?

1

---

(1)  Directive 2004/17/EC of the European Parliament and of the Council of 31 March 2004 coordinating the procurement procedures of entities operating in the water, energy, transport and postal services sectors (OJ 2004 L 134, p. 1).

1

---